DAPAGLIFLOZIN — all Canadian products
40 DINs
38 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is DAPAGLIFLOZIN, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02543192 | ACCEL-DAPAGLIFLOZIN | ACCEL PHARMA INC | Tablet | Oral | DAPAGLIFLOZIN 10 MG | Marketed | |
| 02543184 | ACCEL-DAPAGLIFLOZIN | ACCEL PHARMA INC | Tablet | Oral | DAPAGLIFLOZIN 5 MG | Marketed | |
| 02533049 | AG-DAPAGLIFLOZIN | ANGITA PHARMA INC. | Tablet | Oral | DAPAGLIFLOZIN 5 MG | Marketed | |
| 02533057 | AG-DAPAGLIFLOZIN | ANGITA PHARMA INC. | Tablet | Oral | DAPAGLIFLOZIN 10 MG | Marketed | |
| 02527189 | APO-DAPAGLIFLOZIN | APOTEX INC | Tablet | Oral | DAPAGLIFLOZIN 5 MG | Marketed | |
| 02527197 | APO-DAPAGLIFLOZIN | APOTEX INC | Tablet | Oral | DAPAGLIFLOZIN 10 MG | Marketed | |
| 02536161 | APO-DAPAGLIFLOZIN-METFORMIN | APOTEX INC | Tablet | Oral | DAPAGLIFLOZIN 5 MG; METFORMIN HYDROCHLORIDE 1000 MG | Marketed | |
| 02536153 | APO-DAPAGLIFLOZIN-METFORMIN | APOTEX INC | Tablet | Oral | DAPAGLIFLOZIN 5 MG; METFORMIN HYDROCHLORIDE 850 MG | Marketed | |
| 02531402 | AURO-DAPAGLIFLOZIN | AURO PHARMA INC | Tablet | Oral | DAPAGLIFLOZIN 5 MG | Marketed | |
| 02531410 | AURO-DAPAGLIFLOZIN | AURO PHARMA INC | Tablet | Oral | DAPAGLIFLOZIN 10 MG | Marketed | |
| 02533081 | AURO-DAPAGLIFLOZIN / METFORMIN | AURO PHARMA INC | Tablet | Oral | DAPAGLIFLOZIN 5 MG; METFORMIN HYDROCHLORIDE 1000 MG | Marketed | |
| 02533073 | AURO-DAPAGLIFLOZIN / METFORMIN | AURO PHARMA INC | Tablet | Oral | DAPAGLIFLOZIN 5 MG; METFORMIN HYDROCHLORIDE 850 MG | Marketed | |
| 02561336 | DAPAGLIFLOZIN | SANIS HEALTH INC | Tablet | Oral | DAPAGLIFLOZIN 10 MG | Marketed | |
| 02561328 | DAPAGLIFLOZIN | SANIS HEALTH INC | Tablet | Oral | DAPAGLIFLOZIN 5 MG | Marketed | |
| 02519860 | GLN-DAPAGLIFLOZIN | GLENMARK PHARMACEUTICALS CANADA INC. | Tablet | Oral | DAPAGLIFLOZIN 10 MG | Marketed | |
| 02519852 | GLN-DAPAGLIFLOZIN | GLENMARK PHARMACEUTICALS CANADA INC. | Tablet | Oral | DAPAGLIFLOZIN 5 MG | Marketed | |
| 02531372 | JAMP DAPAGLIFLOZIN | JAMP PHARMA CORPORATION | Tablet | Oral | DAPAGLIFLOZIN 10 MG | Marketed | |
| 02531364 | JAMP DAPAGLIFLOZIN | JAMP PHARMA CORPORATION | Tablet | Oral | DAPAGLIFLOZIN 5 MG | Marketed | |
| 02535297 | M-DAPAGLIFLOZIN | MANTRA PHARMA INC | Tablet | Oral | DAPAGLIFLOZIN 5 MG | Marketed | |
| 02535300 | M-DAPAGLIFLOZIN | MANTRA PHARMA INC | Tablet | Oral | DAPAGLIFLOZIN 10 MG | Marketed | |
| 02559064 | MINT-DAPAGLIFLOZIN | MINT PHARMACEUTICALS INC | Tablet | Oral | DAPAGLIFLOZIN 5 MG | Approved | |
| 02559072 | MINT-DAPAGLIFLOZIN | MINT PHARMACEUTICALS INC | Tablet | Oral | DAPAGLIFLOZIN 10 MG | Approved | |
| 02560941 | NB-DAPAGLIFLOZIN | NB PHARMA INC. | Tablet | Oral | DAPAGLIFLOZIN 10 MG | Approved | |
| 02560933 | NB-DAPAGLIFLOZIN | NB PHARMA INC. | Tablet | Oral | DAPAGLIFLOZIN 5 MG | Approved | |
| 02538334 | NRA-DAPAGLIFLOZIN | NORA PHARMA INC | Tablet | Oral | DAPAGLIFLOZIN 5 MG | Marketed | |
| 02538342 | NRA-DAPAGLIFLOZIN | NORA PHARMA INC | Tablet | Oral | DAPAGLIFLOZIN 10 MG | Marketed | |
| 02531569 | PMS-DAPAGLIFLOZIN | PHARMASCIENCE INC | Tablet | Oral | DAPAGLIFLOZIN 10 MG | Marketed | |
| 02531550 | PMS-DAPAGLIFLOZIN | PHARMASCIENCE INC | Tablet | Oral | DAPAGLIFLOZIN 5 MG | Marketed | |
| 02537664 | PRO-DAPAGLIFLOZIN | PRO DOC LIMITEE | Tablet | Oral | DAPAGLIFLOZIN 10 MG | Marketed | |
| 02537656 | PRO-DAPAGLIFLOZIN | PRO DOC LIMITEE | Tablet | Oral | DAPAGLIFLOZIN 5 MG | Marketed | |
| 02528983 | RIVA-DAPAGLIFLOZIN | LABORATOIRE RIVA INC. | Tablet | Oral | DAPAGLIFLOZIN 10 MG | Marketed | |
| 02528975 | RIVA-DAPAGLIFLOZIN | LABORATOIRE RIVA INC. | Tablet | Oral | DAPAGLIFLOZIN 5 MG | Marketed | |
| 02518740 | SANDOZ DAPAGLIFLOZIN | SANDOZ CANADA INCORPORATED | Tablet | Oral | DAPAGLIFLOZIN 10 MG | Marketed | |
| 02518732 | SANDOZ DAPAGLIFLOZIN | SANDOZ CANADA INCORPORATED | Tablet | Oral | DAPAGLIFLOZIN 5 MG | Marketed | |
| 02520605 | TARO-DAPAGLIFLOZIN | TARO PHARMACEUTICALS INC | Tablet | Oral | DAPAGLIFLOZIN 10 MG | Approved | |
| 02520591 | TARO-DAPAGLIFLOZIN | TARO PHARMACEUTICALS INC | Tablet | Oral | DAPAGLIFLOZIN 5 MG | Approved | |
| 02523604 | TEVA-DAPAGLIFLOZIN | TEVA CANADA LIMITED | Tablet | Oral | DAPAGLIFLOZIN 10 MG | Approved | |
| 02523590 | TEVA-DAPAGLIFLOZIN | TEVA CANADA LIMITED | Tablet | Oral | DAPAGLIFLOZIN 5 MG | Approved | |
| 02535866 | NAT-DAPAGLIFLOZIN | NATCO PHARMA (CANADA) INC | Tablet | Oral | DAPAGLIFLOZIN 5 MG | Cancelled Pre Market | |
| 02535874 | NAT-DAPAGLIFLOZIN | NATCO PHARMA (CANADA) INC | Tablet | Oral | DAPAGLIFLOZIN 10 MG | Cancelled Pre Market |
Browse other molecules: